Brandi Roberts Insider Trades & Stock Holdings

Chief Financial Officer · Definium Therapeutics, Inc. · Latest filing Jun 25, 2026

Brandi Roberts, Chief Financial Officer at Definium Therapeutics, Inc. has 2 Form 4 trades on file since Jun 22, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($135.68K), net -$135.68K. Latest filing: disposed of 3.01K shares of $DFTX on Jun 25, 2026 at $45.03.

Trades on file

2

Open-market bought

$0

Open-market sold

$135.68K

Net open-market

-$135.68K

Latest filing

Jun 25, 2026

All insider trades by Brandi Roberts

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 25, 2026	$DFTX	Sell (Open-market sale) 10b5-1	3.01K	$45.03	$135.68K			-1.3%	-4.8%		Chief Financial Officer		Read
Jun 22, 2026	$DFTX	Buy (Grant or award)	62.50K	$0	—			+26.9%	+19.1%		Chief Financial Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Brandi Roberts traded

• $DFTX

Frequently asked questions

Has Brandi Roberts been buying or selling stock?

Brandi Roberts has 0 open-market purchases and 1 open-market sale on file, net -$135.68K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Brandi Roberts's latest insider trade?

disposed of 3.01K shares of $DFTX on Jun 25, 2026 at $45.03.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.